City of Hope Names New Chief Clinical Operating Officer

City of Hope, one of the largest cancer research and treatment organizations in the United States, today named Vince Jensen as its chief clinical operating officer. Jensen will lead clinical operations on City of Hope’s main campus in Los Angeles and throughout its network of more than 35 care locations in Southern California. He will focus on strategically positioning City of Hope's clinical enterprise for future growth, excellence in care and efficiency.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220210005363/en/

Vince Jensen has been named City of Hope's chief clinical operating officer. (Photo: Business Wire)

Jensen was the biomedical institution’s interim chief clinical operating officer for more than nine months and provided operational leadership for its largest clinical network expansion to date: the addition of Pacific Shores Medical Group. Jensen also led the recent opening of City of Hope | Corona and the opening of a 34,000-square-foot outpatient clinic in Los Angeles as part of City of Hope’s larger campus expansion plan.

“Vince Jensen is a recognized health care executive with nearly three decades of leadership experience in the hospital, medical foundation and large multispecialty group setting. Vince has proven that he has a keen ability to work across the enterprise to fulfill City of Hope’s mission to bring compassionate, leading-edge, specialized cancer care to more patients, regardless of where they live,” said Michael Caligiuri, M.D., president of City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair.

Jensen has served in executive leadership roles for academic and nonacademic health care institutions, where he focused on clinical care operations, health care finance, clinical growth strategy, and health care mergers and acquisitions.

He joined City of Hope more than 21 years ago as a managed care executive and was instrumental in the development of City of Hope’s bone marrow transplant partnership with Kaiser Permanente and in the creation of national centers of excellence relationships — expanding access to City of Hope, especially when patients have complex cancers and need specialized care.

Early on, Jensen helped shape City of Hope's vision to develop a clinical network and bring cancer care closer to patients’ homes. Since 2015, he has led an ambitious growth strategy for City of Hope, successfully expanding its clinical footprint to more than 35 clinical care sites across Southern California. He has been a key, visionary leader in the development of City of Hope’s new campus in Orange County, which is expected to open later this year. Jensen became senior vice president for City of Hope’s ambulatory operations in 2019.

Prior to City of Hope, Jensen served as president and chief operating officer for Sansum Clinic, a health system in Santa Barbara, California. He began his career in the Providence Health System, where he served the Los Angeles Service region in clinical and administrative roles for over a decade before joining City of Hope in 1998. Jensen has a Master of Business Administration from the University of La Verne.

Jensen serves on the board of Alliance of Dedicated Cancer Centers and has served on the board of directors for the California Association of Physician Groups and the Economic Forecast Project for the University of California Santa Barbara.

About City of Hope

City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute-designated comprehensive cancer center, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. Research and technology developed at City of Hope has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. A leader in bone marrow transplantation and immunotherapy, such as CAR T cell therapy, City of Hope’s personalized treatment protocols help advance cancer care throughout the world.

With a goal of expanding access to the latest discoveries and leading-edge care to more patients, families and communities, City of Hope’s growing national system includes its main Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, scheduled to open in 2022, and Cancer Treatment Centers of America. City of Hope’s affiliated family of organizations includes Translational Genomics Research Institute and AccessHope™. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005363/en/